The US market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatment of AV access thrombosis, PADVTECAD, and AIS.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for clot management devices in the US across a 10-year period.


Expansion of endovascular clot management procedure volumes hinges on obtaining conclusive evidence demonstrating the comparative efficacy of these procedures over the current standard of care. 

Which segments will experience the strongest growth in procedure volumes?

Which segments will benefit the most from emerging clinical evidence and to what extent?

How will the expanding use of novel oral anticoagulants affect clot management procedures?

What steps are being taken to increase the usage of clot management devices?

What has been the impact of the recent influx of favorable clinical data in the neurovascular thrombectomy device market?

Results from the ATTRACT clinical trial failed to show the superiority of endovascular treatment for clot management over anticoagulant therapy for treatment of VTE.

How will these negative results impact clot management procedures in the VTE indication?

Will this data have an impact on the overall clot management device market?

The TOTAL clinical trial results have demonstrated no benefit of a routine thrombectomy with a PCI, but suggest the procedure may increase the risk of stroke.

How will these negative results impact clot management procedures in the coronary indication in the US?

Will these data have an impact on the overall clot management device market?

A recent influx of clinical data supporting the effectiveness of neurovascular thrombectomy procedures for the treatment of ischemic stroke has changed the landscape of the US market.

How much growth is expected in this market?

What factors limit growth of this rapidly expanding market?

How will new entrants change the competitive landscape?

How long will robust growth in this market be sustained?

Table of contents

  • United States
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Procedures Covered
      • Products Covered
    • Version History
    • Clot Management Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
        • Product Portfolio Management
        • Clinical Data
        • Product Improvements and Innovations
        • Physician Training and Marketing
      • Market Developments
    • Percutaneous Thrombectomy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Manual Aspiration Thrombectomy Devices
        • Mechanical Thrombectomy Devices
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
        • Clinical Data
        • Product Improvements and Innovations
    • Embolectomy Balloon Catheter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Catheter-Directed Thrombolysis Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Inferior Vena Cava Filter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • Neurovascular Thrombectomy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Physician Training and Marketing
    • Appendix
      • Abbreviations
      • Bibliography
    • Abstract

Author(s): Yang Yun Li, PhD

Yang Yun Li is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in clot management device markets. Yang holds a in Pharmaceutical Sciences from the University of Toronto.


Related Reports

Clot Management Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for clot management devices is characterized by a combination of rapidly expanding and relatively mature market segments, where device adoption hinges largely on positive cli...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Europe

The European market for clot management devices consists of a combination of rapidly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatmen...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Japan

The Japanese market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatme...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the tre...

View Details